FDA, other authorities issue guidelines for good import practices
ROCKVILLE, Md. The Food and Drug Administration, along with eight other government agencies, on Tuesday issued a draft guidance document regarding good importer practices that, when finalized, will represent the current thinking on importing as it pertains to the respective government agency.
Industry has until April 12 to submit comments on the draft legislation.
The other government agencies include: the Department of Homeland Security, the Consumer Product Safety Commission, the Department of Agriculture, the Department of Commerce, the Department of Transportation, the Environmental Protection Agency and the Office of the United States Trade Representative.
CRN praises FDA recall of tainted weight loss supplements
WASHINGTON The Council for Responsible Nutrition on Friday applauded the Food and Drug Administration’s expansion of its recall of 69 tainted products advertised as weight loss dietary supplements.
“It is particularly concerning that some of these weight loss products illegally contain pharmaceutical drugs, which can be especially dangerous and put consumers at risk,” stated Steve Mister, CRN president and chief executive officer. “It is unfortunate that some of these products have been marketed as dietary supplements.
Under the law, what is in the dietary supplement bottle should be listed on the label and products that break the law have no business being on store shelves,” he said. “Regardless of how it is marketed, if a weight loss product contains a drug ingredient, it is a drug under federal law.”
Mister noted that the majority of companies in the dietary supplement industry abide by the law and work hard to provide the more than 150 million Americans who take vitamins and other dietary supplements with safe, high quality and beneficial products. “We encourage consumers to be savvy when it comes to their supplements—always buy from reputable companies that you know and trust,” Mister said.
New study finds pregnant women with glucose intolerance at risk of heart disease
ONTARIO, Canada Mild glucose intolerance in pregnancy may be an early identifier of women who are at increased risk of heart disease in the future, found a new study published in the Canadian Medical Association Journal.
In a large population-based cohort study, researchers from the University of Toronto and the Institute for Clinical Evaluative Sciences studied data on 435,696 women in Ontario, Canada, who gave birth between April, 1994 and March, 1998. All women were followed until March 31, 2008. The study excluded women with pre-existing diabetes.
“Women who had an abnormal glucose challenge test but then did not have gestational diabetes had an increased risk of future cardiovascular disease, compared to the general population, but a lower risk than women who actually did have gestational diabetes,” stated Baiju Shah, Institute for Clinical and Evaluative Sciences and coauthor.
Therefore, current screening procedures for gestational diabetes might also provide a means for the early identification of women who are at risk for developing heart disease later in life.